Kubista E - Search Results

1

Impaired production of tumor necrosis factor in breast cancer.

Zielinski CC, Mueller C, Tyl E, Tichatschek E, Kubista E, Spona J. Zielinski CC, et al. Among authors: kubista e. Cancer. 1990 Nov 1;66(9):1944-8. doi: 10.1002/1097-0142(19901101)66:9<1944::aid-cncr2820660916>3.0.co;2-w. Cancer. 1990. PMID: 2224791

2

Long-term influence of adjuvant therapy on natural killer cell activity in breast cancer.

Tichatschek E, Zielinski CC, Müller C, Sevelda P, Kubista E, Czerwenka K, Spona J, Wolf H, Eibl MM. Tichatschek E, et al. Among authors: kubista e. Cancer Immunol Immunother. 1988;27(3):278-82. doi: 10.1007/BF00205452. Cancer Immunol Immunother. 1988. PMID: 2460239 Free PMC article.

3

Association of increased lytic effector cell function with high estrogen receptor levels in tumor-bearing patients with breast cancer.

Zielinski CC, Tichatschek E, Müller C, Kalinowski W, Sevelda P, Czerwenka K, Kubista E, Spona J. Zielinski CC, et al. Among authors: kubista e. Cancer. 1989 May 15;63(10):1985-9. doi: 10.1002/1097-0142(19890515)63:10<1985::aid-cncr2820631019>3.0.co;2-b. Cancer. 1989. PMID: 2702570

4

Diagnostic value of mucin-like carcinoma-associated antigen (MCA) in breast cancer.

Rasoul-Rockenschaub S, Zielinski CC, Kubista E, Vavra N, Pospischil E, Staffen A, Czerwenka K, Aiginger P, Spona J. Rasoul-Rockenschaub S, et al. Among authors: kubista e. Eur J Cancer Clin Oncol. 1989 Jul;25(7):1067-72. doi: 10.1016/0277-5379(89)90390-8. Eur J Cancer Clin Oncol. 1989. PMID: 2759162

5

Reduced mitogenic stimulation of peripheral blood mononuclear cells as a prognostic parameter for the course of breast cancer: a prospective longitudinal study.

Wiltschke C, Krainer M, Budinsky AC, Berger A, Müller C, Zeillinger R, Speiser P, Kubista E, Eibl M, Zielinski CC. Wiltschke C, et al. Among authors: kubista e. Br J Cancer. 1995 Jun;71(6):1292-6. doi: 10.1038/bjc.1995.250. Br J Cancer. 1995. PMID: 7779726 Free PMC article.

6

Increased natural killer cell activity correlates with low or negative expression of the HER-2/neu oncogene in patients with breast cancer.

Wiltschke C, Tyl E, Speiser P, Steininger A, Zeillinger R, Kury F, Czerwenka K, Kubista E, Preis P, Krainer M, et al. Wiltschke C, et al. Among authors: kubista e. Cancer. 1994 Jan 1;73(1):135-9. doi: 10.1002/1097-0142(19940101)73:1<135::aid-cncr2820730123>3.0.co;2-s. Cancer. 1994. PMID: 7903907

7

Androgen receptors, serum androgen levels and survival of breast cancer patients.

Langer M, Kubista E, Schemper M, Spona J. Langer M, et al. Among authors: kubista e. Arch Gynecol Obstet. 1990;247(4):203-9. doi: 10.1007/BF02389545. Arch Gynecol Obstet. 1990. PMID: 2221994

8

Effects of adjuvant chemotherapy on specific and non-specific immune mechanisms.

Zielinski CC, Müller C, Kubista E, Staffen A, Eibl MM. Zielinski CC, et al. Among authors: kubista e. Acta Med Austriaca. 1990;17(1):11-4. Acta Med Austriaca. 1990. PMID: 2353562

9

HER-2 amplification, steroid receptors and epidermal growth factor receptor in primary breast cancer.

Zeillinger R, Kury F, Czerwenka K, Kubista E, Sliutz G, Knogler W, Huber J, Zielinski C, Reiner G, Jakesz R, et al. Zeillinger R, et al. Among authors: kubista e. Oncogene. 1989 Jan;4(1):109-14. Oncogene. 1989. PMID: 2915900

10

Tissue expression and serum levels of HER-2/neu in patients with breast cancer.

Krainer M, Brodowicz T, Zeillinger R, Wiltschke C, Scholten C, Seifert M, Kubista E, Zielinski CC. Krainer M, et al. Among authors: kubista e. Oncology. 1997 Nov-Dec;54(6):475-81. doi: 10.1159/000227606. Oncology. 1997. PMID: 9394844

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

290 results

Search Page

Filters